Sanai Toru, Okamura Ken, Kishi Tomoya, Miyazono Motoaki, Ikeda Yuji, Kitazono Takanari
The Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga-city, Saga, 849-8501, Japan.
The Department of Nephrology, Abe Clinic, 2-3-8 Taharashin-machi, Kokuraminami-ku, Kitakyushu-city, Fukuoka, 800-0226, Japan.
J Endocrinol Invest. 2015 Jan;38(1):47-56. doi: 10.1007/s40618-014-0121-6. Epub 2014 Jul 5.
BACKGROUND/AIM: We evaluated the thyroid function in end-stage renal disease (ESRD) on maintenance hemodialysis.
MATERIAL/METHODS: Thyroid function and clinical hypothyroid score were evaluated in 145 ESRD patients.
Comparison of thyroid function between 127 ESRD patients, excluding 18 patients with suppressed or elevated serum TSH level, and age/sex-matched healthy controls (76 in midlife group aged under 65 and 51 in late-life group aged 65 or over) using a multivariate logistic regression analysis suggested significant difference (P < 0.0001), mainly in serum fT4 level (P = 0.0099) and age (P = 0.0492), but not in serum fT3 (not significant; ns), TSH (ns) level or fT3/fT4 ratio (ns). Serum fT3 level and fT3/fT4 ratio were significantly lower (P < 0.001) in late-life group only in ESRD. Reference values calculated for midlife ESRD patients, such as 0.6-1.3 ng/dl for fT4 compared with 0.8-1.7 ng/dl for healthy control, were helpful for the diagnosis of mild but definite hyperthyroidism in whom serum fT4 level was 1.5 ng/dl. The prevalence of primary thyroid dysfunction, compared with the values for ESRD, was 0.7 % for hyperthyroidism, 1.4 % for overt hypothyroidism and 10.3 % for subclinical hypothyroidism. Hypothyroid score was high among those with ESRD independent of thyroid dysfunction.
Serum fT4 level was markedly lower without a change in fT3/fT4 ratio in ESRD. This may suggest typical carbohydrate-sufficient non-thyroidal illness. The specific reference values for ESRD were useful to evaluate borderline thyroid dysfunction and to evaluate the prevalence of the patients with primary thyroid dysfunction in ESRD.
背景/目的:我们评估了维持性血液透析的终末期肾病(ESRD)患者的甲状腺功能。
材料/方法:对145例ESRD患者的甲状腺功能和临床甲状腺功能减退评分进行了评估。
采用多因素logistic回归分析,对127例ESRD患者(排除18例血清促甲状腺激素水平受抑制或升高的患者)与年龄/性别匹配的健康对照者(65岁以下中年组76例,65岁及以上老年组51例)的甲状腺功能进行比较,结果显示存在显著差异(P < 0.0001),主要体现在血清游离甲状腺素(fT4)水平(P = 0.0099)和年龄(P = 0.0492)方面,但血清游离三碘甲状腺原氨酸(fT3)、促甲状腺激素(TSH)水平或fT3/fT4比值无显著差异(无显著性差异;ns)。仅在ESRD患者的老年组中,血清fT3水平和fT3/fT4比值显著降低(P < 0.001)。为中年ESRD患者计算的参考值,如fT4为0.6 - 1.3 ng/dl,而健康对照者为0.8 - 1.7 ng/dl,有助于诊断血清fT4水平为1.5 ng/dl的轻度但明确的甲状腺功能亢进。与ESRD患者的值相比,原发性甲状腺功能障碍的患病率为:甲状腺功能亢进0.7%,显性甲状腺功能减退1.4%,亚临床甲状腺功能减退10.3%。无论是否存在甲状腺功能障碍,ESRD患者的甲状腺功能减退评分均较高。
ESRD患者血清fT4水平显著降低,而fT3/fT4比值无变化。这可能提示典型的碳水化合物充足的非甲状腺疾病。ESRD的特定参考值有助于评估临界甲状腺功能障碍以及评估ESRD患者原发性甲状腺功能障碍的患病率。